Literature DB >> 7724176

Orbital infarction syndrome after surgery for intracranial aneurysms.

C F Zimmerman1, P D Van Patten, K C Golnik, T A Kopitnik, R Anand.   

Abstract

BACKGROUND: Global orbital infarction results from ischemia of the intraocular and intraorbital structures due to hypoperfusion of the ophthalmic artery and its branches. PATIENTS: The authors describe six patients in whom acute proptosis, ophthalmoplegia, and blindness developed immediately after surgery for intracranial aneurysms.
RESULTS: All patients underwent standard frontotemporal craniotomies to clip their aneurysms. In all patients, proptosis, ophthalmoplegia, and blindness developed in the immediate postoperative period; fundus abnormalities included retinal edema, retinal arteriolar narrowing and other vascular abnormalities, and pale optic disc swelling. Some patients had facial and corneal anesthesia. Ophthalmoplegia and facial anesthesia improved in most patients, but none regained any vision in the affected eye.
CONCLUSION: Orbital infarction syndrome is a rare complication of neurosurgical procedures. Increased orbital pressure probably reduced ophthalmic artery and collateral arterial perfusion, resulting in ischemia of the intraocular and intraorbital structures. There may be multiple factors that compound the risk for orbital infarction, and patients with subarachnoid hemorrhage, increased intracranial pressure, anomalous arterial or venous circulation, or impaired orbital venous outflow seem particularly vulnerable.

Entities:  

Mesh:

Year:  1995        PMID: 7724176     DOI: 10.1016/s0161-6420(95)30979-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

Review 1.  Exophthalmos following mechanical thrombectomy for anterior circulation stroke: A retrospective study and review of literature.

Authors:  D Volders; M Labrie; M Keezer; A Y Poppe; G Jacquin; C Stapf; L Gioia; Y Deschaintre; C Odier; N Daneault; D Iancu; J Raymond; D Roy; A Weill
Journal:  Interv Neuroradiol       Date:  2020-05-14       Impact factor: 1.610

2.  Orbital congestion complicating treatment of cerebral vascular anomalies.

Authors:  Marc H Levin; Heather E Moss; Stacy L Pineles; Linda J Bagley; Gregory G Heuer; Eric L Zager; Laura J Balcer; Steven L Galetta; M Reza Vagefi
Journal:  World Neurosurg       Date:  2013-01-28       Impact factor: 2.104

3.  Surgical outcomes of strabismus after iatrogenic ophthalmic artery occlusion caused by cosmetic filler injections.

Authors:  Hee Kyung Yang; Se Joon Woo; Seong-Joon Kim; Jeong-Min Hwang
Journal:  BMC Ophthalmol       Date:  2019-12-16       Impact factor: 2.209

4.  Posterior ischemic optic neuropathy with acute monocular vision loss following clipping of anterior communicating artery aneurysm. A case report and review of literature.

Authors:  Amit Kumar Sharma; Binita Dholakia; Anita Jagetia; Ghanshyam Das Singhal; Shaam Bodeliwala; Arvind Kumar Srivastava; Daljit Singh
Journal:  Surg Neurol Int       Date:  2021-09-20

5.  Orbital infarction syndrome after mechanical thrombectomy in acute ischaemic stroke.

Authors:  Adrián Valls Carbó; María Gutiérrez Sánchez de la Fuente; Carlos Pérez García; Maria Natividad Gómez Ruiz
Journal:  BMJ Case Rep       Date:  2020-05-05

6.  Ophthalmic artery occlusion: a cause of unilateral visual loss following spine surgery.

Authors:  Mihir T Kothari; Aniruddha Maiti
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

Review 7.  Orbital infarction syndrome after cerebral aneurysm surgery: A case series and literature review.

Authors:  Sung Won Choi; Kyung Tae Kang; Jong Hwa Jun; Ji Hye Jang; Yu Cheol Kim
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

8.  Bilateral central retinal/ophthalmic artery occlusion and near-complete ophthalmoplegia after bilateral lung transplant.

Authors:  Nadine Rady; Ashwini Kini; Jonathan A Go; Bayan Al Othman; Andrew G Lee
Journal:  Am J Ophthalmol Case Rep       Date:  2019-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.